News
Article
A new survey reveals widespread consumer frustration with prior authorization, highlighting the need for urgent reform in insurance coverage.
About three-quarters of American consumers feel insurer prior authorization (PA) requirements are a problem, according to a survey released today.1
KFF’s Health Tracking Poll gauged consumer experiences with PA a month after 4 dozen insurers pledged to “streamline, simplify, and reduce” PA, the clearance process payers require before patients gain access to certain tests, procedures, or drugs.2,3
The survey found that 51% of respondents had experienced a PA problem in the past 2 years. Majorities of Republicans (57%), Independents (79%), and Democrats (84%) feel that insurers’ delays and denials of services are a “major problem.”1
Mike Tuffin | Image: AHIP
Only 20% of the respondents knew “a lot” or “some” about insurers’ recent pledge to reform PA.1 The pledge was coordinated through the trade association AHIP (America’s Health Insurance Plans), and its June 23, 2025, announcement followed a meeting with HHS Secretary Robert F. Kennedy Jr and CMS Administrator Mehmet Oz, MD, MBA, in Washington, DC.2,3
Plans adopting the pledge include more than 30 Blue Cross Blue Shield entities, as well as large national insurers including UnitedHealthcare, Humana, the Cigna Group, and CVS Health Aetna. Centene, the largest Medicaid insurer, is also participating.2
The pledge comes as physicians from different regions and specialties have complained that PA constraints are worse than ever, are interfering with patient care, and have contributed to burnout among providers.4,5 Consumers experience PA challenges when they cannot take a prescribed drug to treat cancer or get a needed scan to guide care. Sometimes, patients must make their own appeals—and increasingly, they may use artificial intelligence to do so.6
In the survey, 47% of those required to get a PA in the past 2 years found navigating the process “somewhat difficult” (34%) or “very difficult” (13%).1
Insurers say they require PA to ensure that all care is medically necessary and cost-effective. From their view, PA prevents unnecessary procedures and medications, ensuring patient safety and holding down overall costs.7 However, providers and patients say cost has become the overriding priority, and that the process has harmed patients. In 2023, an American Medical Association (AMA) survey found that 1 in 3 doctors could attribute at least 1 adverse event to PA delays.8
On July 18, 2025, The New York Times published an investigation that found denials of medical claims rose 25% from 2016 to 2023, following an analysis of more than 4 billion claims by Komodo Health.9 The analysis attributed many denials to actions by pharmacy benefit managers (PBMs), the largest of which are controlled by the nation’s major insurers, UnitedHealth Group (OptumRx), CVS Aetna (CVS Caremark), and Cigna (Express Scripts).
The AHIP statement said the insurers’ commitments would apply to Medicare Advantage, Medicaid, and commercial plans and would affect 257 million Americans. Promises include adhering to a common set of technology standards, ensuring continuity of care if a patient changes plans, and scaling back what is covered by PA.1
Bipartisan support is growing in the Congress to restrict PA, especially in Medicare Advantage plans. In May, the AMA announced support for a bill that would require “true peers” to make decisions. This change would be especially relevant for specialty fields such as oncology, where there are frequent complaints that insurer representatives lack knowledge of current guidelines or recent scientific advances.10
Some states are acting on their own to address PA problems. A New Jersey law that took effect in January reduces the time insurers have to make PA decisions and requires urgent medication requests to receive action within 24 hours.11
AMA offered cautious praise for the announcement in a statement from President Bobby Mukkamala, MD. He noted that health plans pledged in 2018 and in 2023 to act on PA complaints, but physicians do not see progress.12
“We are pleased with the industry’s recognition that the current system is not working for patients, physicians or plan,” Mukkamala said in a statement.12 “However, patients and physicians will need specifics demonstrating that the latest insurer pledge will yield substantive actions to bring immediate and meaningful changes, break down unnecessary roadblocks, and keep medical decisions between patients and physicians.
“The AMA will closely monitor the implementation and impact of these changes as we continue to work with federal and state policymakers on legislative and regulatory solutions to reduce waste, improve efficiency, and, most importantly, protect patients from obstacles to medically necessary care.”12
The Community Oncology Alliance (COA) has maintained an online archive of patient encounters with both PA and PBM restrictions, which are especially problematic in oncology, because delays of even a few weeks can allow cancer to progress.13 The current COA president, Debra Patt, MD, PhD, MBA, has testified before Congress about PA and PBM abuses.14 In a recent interview, COA Executive Director Ted Okon said he was taking a wait-and-see approach to the latest pledge.
In making their pledge, insurers said recent improvements in technology may finally bridge the gaps physicians and practices experience. Specifically, the AHIP pledge calls for the following1:
“The health care system remains fragmented and burdened by outdated manual processes, resulting in frustration for patients and providers alike. Health plans are making voluntary commitments to deliver a more seamless patient experience and enable providers to focus on patient care, while also helping to modernize the system,” AHIP President and CEO Mike Tuffin said in a statement.1
The Blue Cross Blue Shield Association will work with AHIP to track and report progress.
“These measurable commitments—addressing improvements like timeliness, scope and streamlining—mark a meaningful step forward in our work together to create a better system of health,” Kim Keck, president and CEO, Blue Cross Blue Shield Association, said in the statement. “This is an important foundation to address bigger problems together, at a time when technology and interoperability can deliver real improvements to patient experience.”1
AHIP said information on plan progress will be tracked on the following sites: www.ahip.org/supportingpatients and https://www.bcbs.com/ImprovingPA.
References
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MD
Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MD
2 Commerce Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.